Holy Cross 9th Annual Winter Oncology Symposium

https://www.hconcologysymposium.com/

 

Holy Cross 9th Annual Winter Oncology Symposium
Avatar

Re-Challenging with Immunotherapy in Metastatic NSCLC: Would Retreatment with anti-PD-L1 Develop a Recurrent Side Effect?

By Holy Cross 9th Annual Winter Oncology Symposium FEATURING Ibiayi Dagogo-Jack
By Holy Cross 9th Annual Winter Oncology Symposium FEATURING Ibiayi Dagogo-Jack
325 views
May 15, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy
Lung Cancers
23:25

The Use of EBUS in Early Detection of Lung Cancers

Holy Cross 9th Annual Winter Oncology Symposium

S. Kosseifi

190 views
16:59

PD-L1 Monotherapy vs. PD-L1+Chemo Combination Therapy in Metastatic …

Holy Cross 9th Annual Winter Oncology Symposium

I. Dagogo-Jack

806 views
15:56

Pneumonitis, Thyroiditis, Myocarditis, and Hepatitis as Side Effects…

Holy Cross 9th Annual Winter Oncology Symposium

I. Dagogo-Jack

325 views
05:39

Re-Challenging with Immunotherapy in Metastatic NSCLC: Would Retreat…

Holy Cross 9th Annual Winter Oncology Symposium

I. Dagogo-Jack

325 views
23:13

Targeted Therapy and Related Side Effects in Advanced NSCLC

Holy Cross 9th Annual Winter Oncology Symposium

L. Raez

368 views
15:04

Genomic Profiling for Metastatic NSCLC

Holy Cross 9th Annual Winter Oncology Symposium

D. Drew

602 views
17:27

Stereotactic Radiotherapy in Stage I Lung Cancer

Holy Cross 9th Annual Winter Oncology Symposium

L. Goyal, V. Patel

469 views